This #LymeAwarenessMonth, CLSI is partnering with the Lymex Diagnostic Prize to help bring better diagnostics to patients. Seven Phase 4 teams are advancing to clinical validation and FDA submission, and we’re here to support. >> https://hubs.la/Q03pJbVN0 If you're interested in the diagnosis of Lyme disease in clinical and reference laboratories, check out CLSI M34: Western Blot Assay for Antibodies to Borrelia burgdorferi, than during Lyme Disease Awareness Month. This CLSI guideline provides critical guidance for laboratories performing Western blot assays. Get it here >> https://hubs.la/Q03pJ9HZ0 #LymeDiseaseAwarenessMonth (fb)

Be in the know! The CLSI Outreach Working Group (ORWG), under CLSI's Subcommittee on Antimicrobial Susceptibility Testing (AST), works to efficiently convey information regarding contemporary AST practices, recommendations, and resources to the clinical microbiology community. This CLSI AST News Update highlights current issues related to antimicrobial susceptibility testing (AST) and reporting >> https://hubs.la/Q03nwFWQ0. (fb)